Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrum
Endocrine · 02.04.2026 · 91 (1)
DOI: 10.1007/s12020-026-04593-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine, online erschienen am 02.04.2026. Verfasst von Huannan Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center f…. Hauptthemen laut MEDLINE: Hyperaldosteronism, Aldosterone, Metabolic Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 158 Literaturangaben. Gefördert von: Guangxi Key Research and Development Program, Science and Technology Major Project of Guangxi, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nann…
- Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, 530021, Guangxi, China.
- Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
- Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, 530021, Guangxi, China. mozengnan@gxmu.edu.cn.
- Guangxi Medical University, Nanning, Nanning Shuangyong Road, China. mozengnan@gxmu.edu.cn.
ORCID-Profile: Huannan Wei, Xinyang Long, Mingli Li, Shengzhu Huang, Jianling Li, Zengnan Mo
Förderung
- Guangxi Key Research and Development Program
- Science and Technology Major Project of Guangxi
- National Natural Science Foundation of China
- Major Project of Guangxi Innovation Driven
- Guangxi Key Laboratory for Genomic and Personalized Medicine
Zitieren
APA
Wei, H., Long, X., Li, M., Huang, S., Li, J., & Mo, Z. (2026). Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrum. Endocrine, 91(1). https://doi.org/10.1007/s12020-026-04593-9
Vancouver
Wei H, Long X, Li M, Huang S, Li J, Mo Z. Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrum. Endocrine. 2026;91(1). doi:10.1007/s12020-026-04593-9
BibTeX
@article{Wei2026,
author = {Wei, Huannan and Long, Xinyang and Li, Mingli and Huang, Shengzhu and Li, Jianling and Mo, Zengnan},
title = {Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrum},
journal = {Endocrine},
year = {2026},
volume = {91},
number = {1},
doi = {10.1007/s12020-026-04593-9}
}
EUVIMED